COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
申请人:Wu Guoxian
公开号:US20080188514A1
公开(公告)日:2008-08-07
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
Compounds modulating c-fms and/or c-kit activity and uses therefor
申请人:Zhang Jiazhong
公开号:US20090076046A1
公开(公告)日:2009-03-19
Compounds active on the receptor protein tyrosine kinases c-kit and/or c-fms are provided herewith. Also provided herewith are compositions useful for treatment of c-kit mediated diseases or conditions and/or c-fms-mediated diseases or conditions, and methods for the use thereof.
Compounds modulating c-kit and c-fms activity and uses therefor
申请人:Zhang Chao
公开号:US20070032519A1
公开(公告)日:2007-02-08
Compounds active on the receptor protein tyrosine kinases c-kit and c-fms are provided herewith. Also provided herewith are compositions useful for treatment of c-kit mediated diseases or condition and c-fms-mediated diseases or condition, and methods for the use thereof.
COMPOUNDS MODULATING C-KIT AND C-FMS ACTIVITY AND USES THEREFOR
申请人:Zhang Chao
公开号:US20110166174A1
公开(公告)日:2011-07-07
Compounds active on the receptor protein tyrosine kinases c-kit and c-fms are provided herewith. Also provided herewith are compositions useful for treatment of c-kit mediated diseases or condition and c-fms-mediated diseases or condition, and methods for the use thereof.
Compounds and methods for kinase modulation, and indications therefor
申请人:Plexxikon Inc.
公开号:US08268858B2
公开(公告)日:2012-09-18
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.